Research
Mixed
Sarcopenic obesity (low muscle mass + high visceral fat) carries a significantly higher risk of metabolic syndrome and adverse health outcomes than either condition alone.
If you have excess belly fat but low muscle strength, your risk for metabolic syndrome is extremely high. Focus on resistance training to build muscle while managing diet to reduce visceral fat, rather than just losing weight.
GoodSupportsHIGH confidence
Compared with healthy subjects, the OR of Met-S was 11.59 for sarcopenic obesity and 1.98 for sarcopenia, and the risk for Met-S was significantly higher in sarcopenic obesity [68].
Why this rating
Supported by multiple cross-sectional and longitudinal studies showing high Odds Ratios.
Source
Metabolic Syndrome and Sarcopenia
Hiroki Nishikawa et al. · Nutrients · 2021
DOI 10.3390/nu13103519
narrative_reviewCited 294×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →